Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers

Clinical trial NCT06365970 · WITHDRAWN

Trial details

NCT number: NCT06365970
Sponsor: Ibrahim Halil Sahin
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

MMR-D/MSI-H Colorectal Cancers

Start date: 2025-01-31
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.